Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06686641

Incidence of Macular Edema in a Uveitis Population

Sponsor: Aalborg University Hospital

View on ClinicalTrials.gov

Summary

Macular edema from uveitis is a serious condition that can lead to vision loss. Uveitis is an inflammation inside the eye, and macular edema is when fluid builds up in the central part of the retina, called the macula, which is crucial for clear vision. This fluid buildup can blur vision, sometimes severely. Managing this condition can be challenging and may require several treatments to reduce the fluid and protect sight. While we know macular edema is a common cause of vision loss in uveitis, there's limited data on how often it affects people in Europe

Official title: Incidence of Macular Edema in a Uveitis Population of 1500 Patients

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

1550

Start Date

2024-05-01

Completion Date

2025-02-01

Last Updated

2024-11-13

Healthy Volunteers

No

Interventions

DRUG

Local and systemical treatment

Evaluating the management of the edema including topical/local treatment (dexamethasone and NSAID, periocular injections, and dexamethasone intravitreal implant) and systemic treatment (prednisolone, DMARD, and biological agents, for example TNF-alpha inhibitors and interleukin-6 inhibitors). Moreover, the duration of any treatment as well as numbers of injections or implants.

Locations (1)

Aalborg University Hospital

Aalborg, North Denmark, Denmark